Literature DB >> 8830046

Cloning of cDNA encoding for a novel isozyme of fructose 6-phosphate, 2-kinase/fructose 2,6-bisphosphatase from human placenta.

A Sakai1, M Kato, M Fukasawa, M Ishiguro, E Furuya, R Sakakibara.   

Abstract

Two independent cDNA clones encoding fructose 6-phosphate, 2-kinase/fructose 2,6-bisphosphatase were isolated from a human placental cDNA library. The deduced amino acid sequences showed that one of the clones, 2K-1, was almost identical to the rat testis isozyme and the other, 2K-3, was different from any known isozymes expressed in mammalian tissues. The results of Southern blot analysis suggested that clones 2K-1 and 2K-3 were encoded as single copy genes and located in different parts of the genome. Since open reading frames of the cDNA clones were not complete, we obtained the 5'-end of the clone 2K-3 cDNA using the 5'-rapid amplification of cDNA end method. The entire cDNA (HP; 1,756 bp) had a coding capacity of 519 amino acids (M(r) = 59,410), and putative phosphorylation sites for protein kinases A and C on the C terminus. Northern blot analysis using a fragment of the HP as a probe showed that a major band of 5.4 kb, significantly different in size from known isozyme mRNAs such as liver (2.1 kb), muscle (1.9 kb), heart (4.0 kb), and testis (2.0 kb), was present in poly(A)+RNA preparations of human first trimester and term placentae. These results strongly suggested that this 5.4 kb mRNA codes a novel isozyme of fructose 6-phosphate,2-kinase/fructose 2,6-bisphosphatase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8830046     DOI: 10.1093/oxfordjournals.jbchem.a021270

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  11 in total

Review 1.  6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis.

Authors:  Mark H Rider; Luc Bertrand; Didier Vertommen; Paul A Michels; Guy G Rousseau; Louis Hue
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

2.  Molecular basis of the fructose-2,6-bisphosphatase reaction of PFKFB3: transition state and the C-terminal function.

Authors:  Michael C Cavalier; Song-Gun Kim; David Neau; Yong-Hwan Lee
Journal:  Proteins       Date:  2012-01-31

3.  Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect.

Authors:  Alexander Minchenko; Irene Leshchinsky; Irina Opentanova; Nianli Sang; Vickram Srinivas; Valerie Armstead; Jaime Caro
Journal:  J Biol Chem       Date:  2001-12-14       Impact factor: 5.157

4.  The third human isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) map position 10p14-p15.

Authors:  J Nicholl; J A Hamilton; G R Sutherland; R L Sutherland; C K Watts
Journal:  Chromosome Res       Date:  1997-04       Impact factor: 5.239

5.  An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect.

Authors:  J Chesney; R Mitchell; F Benigni; M Bacher; L Spiegel; Y Al-Abed; J H Han; C Metz; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 6.  Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux.

Authors:  Brandon C Jones; Paula R Pohlmann; Robert Clarke; Surojeet Sengupta
Journal:  Cancer Metastasis Rev       Date:  2022-04-14       Impact factor: 9.237

7.  Differentiation stage-specific requirement in hypoxia-inducible factor-1alpha-regulated glycolytic pathway during murine B cell development in bone marrow.

Authors:  Hidefumi Kojima; Ayano Kobayashi; Daisuke Sakurai; Yumiko Kanno; Hidenori Hase; Riichi Takahashi; Yoshikazu Totsuka; Gregg L Semenza; Michail V Sitkovsky; Tetsuji Kobata
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

Review 8.  Hypoxia, glucose metabolism and the Warburg's effect.

Authors:  Ramon Bartrons; Jaime Caro
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

9.  The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition.

Authors:  Besa Emini Veseli; Pieter Van Wielendaele; Mirela Delibegovic; Wim Martinet; Guido R Y De Meyer
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

10.  Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism.

Authors:  Susana Ros; Almut Schulze
Journal:  Cancer Metab       Date:  2013-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.